Search Results - "Pepplinkhuizen, S"

Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator? by van der Stuijt, W., Pepplinkhuizen, S., de Veld, J.A., Quast, A.B.E., van Halm, V.P., Bijsterveld, N.R., Olde Nordkamp, L.R.A., Wilde, A.A.M., Smeding, L., Knops, R.E.

“…The first step-down defibrillation studies in the subcutaneous implantable cardioverter-defibrillator (S-ICD) described a defibrillation threshold (DFT) of…”
Get full text

Worsening tricuspid regurgitation after ICD implantation is rather due to transvenous lead than natural progression by Breeman, K.T.N., Peijster, A.J.L., De Bruin-Bon, H.A.C.M., Pepplinkhuizen, S., Van der Stuijt, W., De Veld, J.A., Beurskens, N.E.G., Stuiver, M.M., Wilde, A.A.M., Tjong, F.V.Y., Knops, R.E.

“…Transvenous implantable cardioverter-defibrillators (TV-ICDs) are associated with greater tricuspid regurgitation (TR) severity, which leads to increased…”
Get full text

Sex differences in shocks and device-related complications in subcutaneous implantable-cardioverter defibrillator patients by De Veld, J, Sivanesan, S, Pepplinkhuizen, S, Smeding, L, Knops, R E

“…Abstract Background The use of implantable cardioverter-defibrillators (ICDs) improves the life expectancy of patients at risk of sudden cardiac death…”
Get full text

The eligibility of patients with an inherited cardiac disease for therapy with a subcutaneous implantable cardioverter-defibrillator by Proost, V M, Van Der Stuijt, W, Pepplinkhuizen, S, Knops, R E, Wilde, A A M

“…Abstract Introduction The subcutaneous implantable cardioverter-defibrillator (S-ICD) is considered especially beneficial in young patients with an inherited…”
Get full text

Clinical relevance of the single-lead ECG of the Apple Watch by Pepplinkhuizen, S, Hoeksema, W F, Van Der Stuijt, W, Smeding, L, Wilde, A A M, Knops, R E

“…Abstract Introduction The Apple Watch (AW) is one of the first commercially available wearable with built-in electrocardiogram (ECG) electrodes to perform a…”
Get full text

Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation by Pepplinkhuizen, S, Kors, N, De Veld, J A, Dijkshoorn, L A, Bijsterveld, N R, De Weger, A, Smeding, L, Wilde, A A M, Olde Nordkamp, L R A, Knops, R E

“…Abstract Introduction The PRAETORIAN trial, which randomized S-ICD versus TV-ICD in patients with a class I or IIa indication for ICD therapy, showed that…”
Get full text

Reasons for replacement and extraction of the subcutaneous implantable cardioverter-defibrillator in a large cohort by Van Der Stuijt, W, Pepplinkhuizen, S, Smeding, L, Olde Nordkamp, LRA, Wilde, AAM, Knops, RE

“…Abstract Funding Acknowledgements Type of funding sources: None. Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is proven to be a…”
Get full text

Listen to your heart: The effect of music on heart rate variability by Marsman, E M J, Van Steijn, N J, Pepplinkhuizen, S, De Haas, L M, Lamerigts, K L, Kleer, P S, Ten Berg, S, Nieuwkerk, A C, Kacuk, I T, De Veld, J A, Peltenburg, P J, Van Trier, T J, Winter, M M

“…Abstract Background Heart rate variability (HRV) is indicative of autonomic balance. High HRV during sinus rhythm is associated with reduced morbidity and…”
Get full text

Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial by Pepplinkhuizen, S, Olde Nordkamp, L R A, Kuschyk, J, Bonnemeier, H, El-Chami, M F, De Weger, A, Van Der Stuijt, W, Smeding, L, Bijsterveld, N R, Richter, S, Boersma, L V A, Betts, T R, Wilde, A A M, Knops, R E

“…Abstract Introduction The subcutaneous ICD (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD…”
Get full text

Defibrillation success after subcutaneous implantable cardioverter-defibrillator generator replacement is not affected by impedance increase by Van Der Stuijt, W, Pepplinkhuizen, S, Quast, ABE, Smeding, L, Olde Nordkamp, LRA, Wilde, AAM, Knops, RE

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Routine defibrillation testing during implant and replacement of the subcutaneous…”
Get full text

Exercise-optimized programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation S-ICDs by Pepplinkhuizen, S, Van Der Stuijt, W, Kooiman, KM, Quast, A-F BE, Oosterwerff, FJ, Smeding, L, Olde Nordkamp, LRA, Delnoy, P-P HM, Wilde, AAM, Knops, RE

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Implantable cardioverter-defibrillator (ICD) therapy is associated with the risk of…”
Get full text

Clinical relevance of the single-lead ECG of the Apple Watch by Pepplinkhuizen, S, Hoeksema, W F, Van Der Stuijt, W, Smeding, L, Wilde, A A M, Knops, R E

“…Abstract Introduction The Apple Watch (AW) is one of the first commercially available wearable with built-in electrocardiogram (ECG) electrodes to perform a…”
Get full text

Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence by Pepplinkhuizen, S, Delnoy, PPHM, Olde Nordkamp, LRA, Kuschyk, J, Bonnemeier, H, Bijsterveld, NR, Boersma, LVA, El-Chami, MF, Smeding, L, Van Der Stuijt, W, De Weger, A, Richter, S, Betts, TR, Wilde, AAM, Knops, RE

“…Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Corporation Background The PRAETORIAN…”
Get full text